| Literature DB >> 32774846 |
Antero Fernandes1,2, Jéssica Rodrigues3, Luís Antunes3,4, Patrícia Lages1, Carla Salomé Santos5, Daniel Moreira-Gonçalves1,6, Rafael S Costa7,8, Joaquim Abreu Sousa9, Mário Dinis-Ribeiro10, Lúcio Lara Santos1,5,9.
Abstract
BACKGROUND: Gastrointestinal cancer surgery continues to be a significant cause of postoperative complications and mortality in high-risk patients. It is crucial to identify these patients. Our study aimed to evaluate the accuracy of specific perioperative risk assessment tools to predict postoperative complications, identifying the most informative variables and combining them to test their prediction ability as a new score.Entities:
Keywords: Oncological digestive surgeries; Postoperative complications; Prediction of mortality; Preoperative risk scoring
Year: 2020 PMID: 32774846 PMCID: PMC7409477 DOI: 10.1186/s13741-020-00151-7
Source DB: PubMed Journal: Perioper Med (Lond) ISSN: 2047-0525
Characteristics of the 341 GI cancer patients admitted at the SICU
| Characteristics | No. (%) |
|---|---|
| Age at admission, mean (min–max) | 68 (22–94) |
| Gender | |
| F | 137 (40.2) |
| M | 204 (59.8) |
| Neoadjuvant chemotherapy | |
| No | 226 (66.3) |
| Yes | 115 (33.7) |
| Type of surgery ( | |
| Elective | 278 (81.5) |
| Reoperations | 63 (18.5) |
| ASA | |
| 2 | 139 (40.9) |
| 3 | 176 (51.7) |
| 4 | 25 (7.4) |
| Surgical category | |
| Colorectal | 103 (30.2) |
| Esophageal–gastric | 60 (17.6) |
| Hepatic | 46 (13.5) |
| Urgent laparotomies | 47 (13.8) |
| Hyperthermic intraperitoneal chemotherapy (HIPEC) | 40 (11.7) |
| Pancreatic | 19 (5.6) |
| Other | 26 (7.6) |
| Overall complications | 181 (53.1) |
| Clavien-Dindo classification | |
| Grade I | 14 (7.7) |
| Grade II | 82 (45.3) |
| Grade IIIA | 24 (13.3) |
| Grade IIIB | 25 (13.8) |
| Grade IVA | 10 (5.5) |
| Grade IVB | 12 (6.6) |
| Grade V | 14 (7.7) |
| Mortality | |
| 30 D | 12 (3.5) |
| 90 D | 22 (6.5) |
F female, M male, D days
Fig. 1Venn diagram showing the relationship between different risk assessment tools in detecting high-risk and low-risk patients
Hosmer–Lemeshow goodness of fit test for P-Possum for postoperative complications
| Deciles of risk (%) | Number of patients | Number of observed complications | Number of expected complications | Mean risk | O:E (95% CI) | X |
|---|---|---|---|---|---|---|
| 0–10 | 40 | 4 | 3.92 | 0.10 | 1.02 (0.27–2.61) | 0.00 |
| 10–20 | 44 | 4 | 5.22 | 0.12 | 0.77 (0.21–1.96) | 0.32 |
| 20–30 | 24 | 4 | 3.26 | 0.14 | 1.23 (0.33–3.14) | 0.19 |
| 30–40 | 32 | 6 | 4.98 | 0.16 | 1.20 (0.44–2.62) | 0.25 |
| 40–50 | 47 | 11 | 9.24 | 0.20 | 1.19 (0.59–2.13) | 0.42 |
| 50–60 | 27 | 6 | 6.30 | 0.23 | 0.95 (0.35–2.07) | 0.02 |
| 60–70 | 29 | 6 | 7.87 | 0.27 | 0.76 (0.28–1.66) | 0.61 |
| 70–80 | 35 | 10 | 11.29 | 0.32 | 0.89 (0.42–1.63) | 0.22 |
| 80–90 | 33 | 14 | 13.80 | 0.42 | 1.01 (0.55–1.70) | 0.01 |
| 90–100 | 30 | 20 | 19.12 | 0.64 | 1.05 (0.64–1.62) | 0.11 |
| 0–100 | 341 | 85 | 85 | 1.00 (0.80–1.22) | 2.14 |
X2HL statistic = 2.144; df = 8; P = 0.976
Hosmer–Lemeshow goodness of fit test for ACS NSQIP for postoperative complications
| Deciles of risk (%) | Number of patients | Number of observed complications | Number of expected complications | Mean risk | O:E (95% CI) | X |
|---|---|---|---|---|---|---|
| 0–10 | 34 | 1 | 2.12 | 0.06 | 0.47 (0.01–2.63) | 0.63 |
| 10–20 | 35 | 2 | 3.00 | 0.09 | 0.67 (0.07–2.41) | 0.37 |
| 20–30 | 33 | 2 | 3.62 | 0.11 | 0.55 (0.06–1.99) | 0.82 |
| 30–40 | 34 | 8 | 4.98 | 0.15 | 1.61 (0.69–3.17) | 2.15 |
| 40–50 | 36 | 3 | 6.29 | 0.17 | 0.48 (0.10–1.39) | 2.09 |
| 50–60 | 32 | 10 | 6.71 | 0.21 | 1.49 (0.71–2.74) | 2.04 |
| 60–70 | 34 | 15 | 8.72 | 0.26 | 1.72 (0.96–2.84) | 6.08 |
| 70–80 | 35 | 10 | 11.13 | 0.32 | 0.90 (0.43–1.65) | 0.17 |
| 80–90 | 33 | 9 | 14.69 | 0.45 | 0.61 (0.28–1.16) | 3.98 |
| 90–100 | 34 | 25 | 23.73 | 0.70 | 1.05 (0.68–1.56) | 0.22 |
| 0–100 | 340 | 85 | 85 | 1.00 (0.80–1.22) | 18.54 |
X2HL statistic = 18.540; df = 8; P = 0.018
Association between explanatory variables and major postoperative complications (Clavien-Dindo ≥ 3)
| Variable | OR (95% CI) | |
|---|---|---|
| Age | 0.99 (0.97–1.01) | 0.240 |
| Gender | ||
| F | 1 | |
| M | 3.53 (1.97–6.34) | < 0.001 |
| Neoadjuvant chemotherapy | ||
| No | 1 | |
| Yes | 0.66 (0.38–1.14) | 0.135 |
| Surgery type | ||
| Elective | 1 | |
| Reoperations | 7.47 (4.12–13.53) | < 0.001 |
| ASA | ||
| 2 | 1 | |
| 3 | 1.67 (0.94–2.95) | 0.080 |
| 4 | 21.27 (7.22–62.68) | < 0.001 |
| P-Possum | ||
| Physiological | 1.11 (1.07–1.15) | < 0.001 |
| Surgical severity | 1.20 (1.14–1.27) | < 0.001 |
| ACS NSQIP | 1.09 (1.06–1.11) | < 0.001 |
| ARISCAT | 1.03 (1.01–1.05) | 0.001 |
F female, M male
Significancy of variables involved in MyIPOriskScore
| Variables | OR | 95% CI for OR | |
|---|---|---|---|
| Lower | Upper | ||
| Age | 0.96 | 0.93 | 0.98 |
| Gender (M/F) | 2.94 | 1.52 | 5.71 |
| PP (physiological) | 1.08 | 1.03 | 1.12 |
| ACS NSQIP (serious complication) | 1.06 | 1.03 | 1.09 |
F female, M male
Hosmer–Lemeshow goodness of fit test for MyIPOriskScore for postoperative complications
| Deciles of risk (%) | Number of patients | Number of observed complications | Number of expected complications | Mean risk | O:E (95% CI) | X |
|---|---|---|---|---|---|---|
| 0–10 | 34 | 2 | 1.15 | 0.03 | 1.75 (0.20–6.30) | 0.66 |
| 10–20 | 34 | 0 | 2.07 | 0.06 | 0.00 (-) | 2.20 |
| 20–30 | 34 | 3 | 3.06 | 0.09 | 0.98 (0.20–2.86) | 0.00 |
| 30–40 | 34 | 4 | 4.01 | 0.12 | 1.00 (0.27–2.55) | 0.00 |
| 40–50 | 34 | 7 | 5.25 | 0.15 | 1.33 (0.53–2.75) | 0.69 |
| 50–60 | 34 | 8 | 6.34 | 0.19 | 1.26 (0.54–2.49) | 0.53 |
| 60–70 | 34 | 7 | 8.40 | 0.25 | 0.83 (0.33–1.72) | 0.31 |
| 70–80 | 34 | 11 | 10.91 | 0.32 | 1.01 (0.50–1.80) | 0.00 |
| 80–90 | 34 | 16 | 16.42 | 0.48 | 0.97 (0.56–1.58) | 0.02 |
| 90–100 | 34 | 27 | 27.39 | 0.81 | 0.99 (0.65–1.43) | 0.03 |
| 0–100 | 340 | 85 | 85 | 1.00 (0.80–1.22) | 4.44 |
X2HL statistic = 4.440; df = 8; P = 0.815
Fig. 2ROC curve for the P-Possum, ACS NSQIP, ARISCAT, and MyIPOrisk-score scoring systems for predicting the rate of postoperative morbidity (i.e., complications according to the Clavien-Dindo classification) in patients undergoing GICS. ROC receiver operating characteristic, AUC area under the curve